Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to 15.39%.

  • Orthopediatrics' EBITDA Margin fell 51900.0% to 15.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.84%, marking a year-over-year decrease of 45400.0%. This contributed to the annual value of 17.1% for FY2024, which is 8900.0% up from last year.
  • Per Orthopediatrics' latest filing, its EBITDA Margin stood at 15.39% for Q3 2025, which was down 51900.0% from 17.45% recorded in Q2 2025.
  • Orthopediatrics' EBITDA Margin's 5-year high stood at 10.2% during Q3 2024, with a 5-year trough of 27.83% in Q1 2021.
  • In the last 5 years, Orthopediatrics' EBITDA Margin had a median value of 19.92% in 2022 and averaged 18.84%.
  • In the last 5 years, Orthopediatrics' EBITDA Margin surged by 449300bps in 2021 and then plummeted by -67200bps in 2025.
  • Orthopediatrics' EBITDA Margin (Quarter) stood at 22.41% in 2021, then fell by -20bps to 26.81% in 2022, then grew by 20bps to 21.44% in 2023, then dropped by -24bps to 26.69% in 2024, then skyrocketed by 42bps to 15.39% in 2025.
  • Its last three reported values are 15.39% in Q3 2025, 17.45% for Q2 2025, and 20.95% during Q1 2025.